未登录
分享
收藏
分享
收藏
分享
收藏Immunogenicity and safety of Papilloguard® 4, the first quadrivalent HPV vaccine combined with adjuvant system 04, versus Gardasil® in healthy 15-25-year-old individuals: a phase III, randomized, double-blind, non-inferiority trialPapilloguard® 4(含佐剂系统04的四价HPV疫苗)与Gardasil®在健康15-25岁个体中的免疫原性和安全性比较:一项III期、随机、双盲、非劣效性试验
Mardani, Masoud; Darazam, Ilad Alavi; Moini, Ashraf; Ebrahimi, Ali; Mirhassani, Reihaneh; Barati, Saghar; Shahpari, Ramin; Modiri, Golnoosh; Fallah, Newsha; Albooyeh, Sogol; Neyshaburinezhad, Navid; Karimi-Zarchi, Mojgan; Kashanian, Maryam; Sabzvari, Araz; Kafi, Hamidreza
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Treatment of Adults Patients with Acute Bacterial Rhinosinusitis: Official Practice Guideline of the Infectious Diseases and Tropical Medicine Research Center Advisory Committee成人急性细菌性鼻窦炎患者的治疗:传染病与热带医学研究中心顾问委员会官方实践指南
Roshanzamiri, Soheil; Jahanshahi, Amirali; Yadegarinia, Davood; Mardani, Masoud; Shokohi, Shervin; Rajabi, Amir; Dehghan, Nima; Vahedi, Pooya; Ramezani, Mohammad Hossein; Alavidarazam, Ilad
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-upSARS-CoV-2 mRNA疫苗COReNAPCIN作为伊朗健康成年人的第四种异源加强剂的安全性和免疫原性: 一项双盲,随机,安慰剂对照的1期临床试验,为期六个月的随访
Salehi, Mohammadreza; Darazam, Ilad Alavi; Nematollahi, Alireza; Alimohammadi, Masoumeh; Pouya, Sedigheh; Alimohammadi, Reza; Khajavirad, Nasim; Porgoo, Meysam; Sedghi, Mosslim; Sepahi, Mohammad Mahdi; Azimi, Maryam; Hosseini, Hamed; Hashemi, Seyed Mahmoud; Dehghanizadeh, Somaye; Khoddami, Vahid
分享
收藏